Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Rebecca Liang
BERN
Rebecca Liang
Bernstein
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-7.0%
Average Return
0 of 1 calls profitable · -20.2% vs benchmark
📈 Across the calls we could measure, roughly 0% of Rebecca Liang's ratings turned a profit when each position was held for 1 year — averaging -7.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

20 Buy 13 Hold 0 Sell
Rebecca's Stock Coverage 8 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
HK:9926
Akeso, Inc.
 May 31, 2026 HOLD Strong Buy
+102.1% avg upside
3 analysts
$130.00
48.55% Upside
 ·
HK:3692
Hansoh Pharmaceutical Group Company Limited
 Apr 22, 2026 BUY Strong Buy
+31.6% avg upside
5 analysts
$47.00
56.80% Upside
 ·
HK:6990
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H
 Mar 26, 2026 BUY Strong Buy
+19.2% avg upside
3 analysts
$526.00
26.41% Upside
 ·
ONC
BeOne Medicines
 Mar 18, 2026 BUY Strong Buy
+28.4% avg upside
28 analysts
$412.00
52.60% Upside
 -7.0%
HK:1801
Innovent Biologics
 Mar 12, 2026 BUY Strong Buy
+32.6% avg upside
7 analysts
$115.00
51.06% Upside
 ·
HK:1177
Sino Biopharmaceutical
 Feb 09, 2026 HOLD Strong Buy
+74.6% avg upside
6 analysts
$7.90
72.56% Upside
 ·
HK:9688
Zai Lab Ltd
 Feb 09, 2026 HOLD Buy
+93.0% avg upside
2 analysts
$18.00
25.39% Upside
 ·
HK:1093
CSPC Pharmaceutical Group
 Feb 09, 2026 HOLD Strong Buy
+61.5% avg upside
6 analysts
$10.70
55.33% Upside
 ·
🔒 3 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Rebecca Liang — Frequently Asked Questions
How accurate are Rebecca Liang's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Rebecca's ratings were profitable over a one-year hold, with an average return of -7.0% per rating, or -20.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Rebecca ranked on 13Foresight?
Rebecca Liang is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Rebecca cover?
Rebecca most recently has ratings on HK:9926, HK:3692, HK:6990, ONC, HK:1801, HK:1177, HK:9688, HK:1093. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.